Definition
Acetylcysteine, also known as N‑acetylcysteine (NAC), is a pharmaceutical compound and dietary supplement that is a derivative of the amino acid cysteine. It is employed medically as a mucolytic agent, an antidote for acetaminophen (paracetamol) poisoning, and as an antioxidant therapy in various clinical contexts.
Overview
Acetylcysteine functions primarily by donating a thiol (‑SH) group, which facilitates the reduction of disulfide bonds in mucoproteins, thereby decreasing mucus viscosity in the respiratory tract. In cases of acetaminophen overdose, it replenishes hepatic glutathione stores, enhancing the detoxification of the toxic metabolite N‑acetyl‑p‑benzoquinone imine (NAPQI). Oral, inhalational, and intravenous formulations are available, each indicated for specific therapeutic purposes. Besides its established clinical uses, acetylcysteine is investigated for potential benefits in psychiatric disorders, neurodegenerative diseases, and as a general antioxidant supplement, though evidence for many of these indications remains under active research.
Etymology/Origin
The name “acetylcysteine” combines “acetyl,” referring to the acetyl functional group (CH₃CO‑) attached to the nitrogen atom of the cysteine molecule, and “cysteine,” the parent α‑amino acid containing a sulfhydryl side chain. The compound was first synthesized in the mid‑20th century as a stable, water‑soluble form of cysteine.
Characteristics
- Chemical Formula: C₅H₉NO₃S
- Molecular Weight: 163.19 g·mol⁻¹
- Physical State: White to off‑white crystalline powder; odorless to faintly sulfurous.
- Solubility: Highly soluble in water; limited solubility in organic solvents such as ethanol.
- Pharmacokinetics: Oral bioavailability is variable (≈ 10–20 %); peak plasma concentrations occur within 1–2 hours post‑administration. Intravenous administration yields rapid systemic exposure. It is metabolized primarily to cysteine and subsequently to glutathione; renal excretion accounts for the majority of elimination.
- Mechanism of Action:
- Mucolytic: Reduces inter‑molecular disulfide linkages in mucin glycoproteins, lowering mucus viscosity.
- Antidotal: Supplies cysteine for de novo synthesis of glutathione, neutralizing NAPQI in acetaminophen toxicity.
- Antioxidant: Directly scavenges reactive oxygen species (ROS) and restores intracellular redox balance via glutathione synthesis.
- Therapeutic Dosages (selected):
- Mucolytic (oral): 600 mg 2–3 times daily.
- Acetaminophen overdose (intravenous): Loading dose of 150 mg/kg over 1 hour, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours (standard 21‑hour protocol).
Related Topics
- Mucolytic agents – Medications such as carbocisteine and ambroxol that also reduce mucus viscosity.
- Glutathione – A tripeptide antioxidant whose synthesis is supported by cysteine donors like acetylcysteine.
- Acetaminophen toxicity – A common drug overdose scenario wherein acetylcysteine is the first‑line antidote.
- Antioxidant therapy – Clinical interventions aimed at mitigating oxidative stress, a category in which acetylcysteine is frequently discussed.
- Respiratory diseases – Conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis where mucolytic treatment is applied.
Note: While acetylcysteine is widely recognized and documented in pharmacological literature, ongoing research continues to evaluate additional therapeutic roles.